Phacoemulsification Systems for Cataract

(CDE Trial)

This trial compares two different phacoemulsification systems, which are devices used in cataract surgery, to determine their impact on the time required to remove cataracts. Researchers will use each system on different eyes of the same person to evaluate which one performs better. The trial seeks participants planning cataract surgery in both eyes, with cataracts that are not too complicated. Participants should have common cataracts, which are cloudy areas in the lens of the eye, requiring surgery in both eyes. As an unphased trial, this study allows participants to contribute to advancements in cataract surgery techniques.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.

Studies have shown that both the Centurion and Unity VCS/CS systems are generally safe for cataract surgery. The Centurion system employs a pressure sensor to maintain stability during the operation, quickly detecting and adjusting to changes to prevent issues. Research indicates that the Unity VCS/CS system uses less energy, which can be gentler on the eye and may lead to fewer side effects. It also stabilizes the eye, enhancing safety. Both systems represent advanced technologies designed to make cataract surgery safer and more effective.¹²³⁴⁵

Researchers are excited about these phacoemulsification systems for cataract surgery because they introduce advanced technologies that could improve surgical outcomes. The Centurion vision system with OZil Handpiece uses innovative OZil technology, which enhances the emulsification of the cataract, potentially offering more precision and less stress on the eye during surgery. On the other hand, the Unity VCS/CS with the 4D Phaco Handpiece brings a 4D technology approach, aiming for better fluidic management and more efficient cataract removal. These advancements could lead to quicker recovery times and improved vision results compared to existing phacoemulsification systems.

This trial will compare the Centurion vision system with the OZil Handpiece and the Unity VCS/CS system with 4D Phaco technology for cataract surgery. Studies have shown that the Centurion system increases efficiency in cataract surgery by using less energy, which helps maintain lower eye pressure and reduces complications during the procedure. In contrast, the Unity VCS/CS system effectively breaks up cataracts quickly while using 41% less energy, potentially leading to faster recovery times and fewer side effects. Both systems aim to improve surgical outcomes by enhancing precision and reducing the risk of eye damage.³⁴⁶⁷⁸